-
1دورية أكاديمية
المؤلفون: Shota Takahashi, MD, Yuki Sato, MD, Yoshiharu Sato, PhD, Ryosuke Hirabayashi, MD, Shigeo Hara, MD, PhD, Yutaka Takahashi, MD, PhD, Keisuke Tomii, MD, PhD
المصدر: JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100639- (2024)
مصطلحات موضوعية: Acquired resistance, Histologic transformation, Osimertinib, Immune checkpoint inhibitor, Case report, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Daisuke Hazama, MD, PhD, Kenji Nakahama, MD, PhD, Hiroaki Kodama, MD, Akito Miyazaki, MD, Koichi Azuma, MD, PhD, Yosuke Kawashima, MD, Yuki Sato, MD, Kentaro Ito, MD, Yoshimasa Shiraishi, MD, Keita Miura, MD, Takayuki Takahama, MD, PhD, Satoshi Oizumi, MD, PhD, Yoshinobu Namba, MD, Satoshi Ikeda, MD, PhD, Hiroshige Yoshioka, MD, PhD, Asuka Tsuya, MD, PhD, Yuichiro Yasuda, MD, PhD, Yoshiki Negi, MD, PhD, Ayako Hara, MD, Michihito Toda, MD, PhD, Motoko Tachihara, MD, PhD
المصدر: JTO Clinical and Research Reports, Vol 5, Iss 1, Pp 100613- (2024)
مصطلحات موضوعية: Pulmonary sarcomatoid carcinoma, Immune checkpoint inhibitors, Real-world data, Lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Yuki Sato, MD, Satoru Fujiwara, MD, Akito Hata, MD, Yoko Kida, MD, Takahiro Masuda, MD, Hisanori Amimoto, MD, Hirotaka Matsumoto, MD, Kotoko Miyoshi, MD, Kojiro Otsuka, MD, PhD, Keisuke Tomii, MD, PhD
المصدر: JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100608- (2023)
مصطلحات موضوعية: Small-cell lung cancer, Immune-related adverse event, Autoantibody, Paraneoplastic autoantibody, Paraneoplastic neurologic syndrome, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Yasunori Murata, MD, PhD, Shigeru Tanzawa, MD, PhD, Toshihiro Misumi, PhD, Hiroshige Yoshioka, MD, PhD, Eisaku Miyauchi, MD, PhD, Kiichiro Ninomiya, MD, PhD, Masafumi Takeshita, MD, PhD, Kensaku Ito, MD, PhD, Tatsuro Okamoto, MD, PhD, Shunichi Sugawara, MD, PhD, Yosuke Kawashima, MD, Kazuki Hashimoto, MD, Masahide Mori, MD, PhD, Akihiko Miyanaga, MD, PhD, Anna Hayashi, MD, Hisashi Tanaka, MD, PhD, Ryoichi Honda, MD, PhD, Masafumi Nojiri, MD, PhD, Yuki Sato, MD, Akito Hata, MD, Ken Masuda, MD, PhD, Toshiyuki Kozuki, MD, PhD, Takahisa Kawamura, MD, PhD, Takuji Suzuki, MD, PhD, Teppei Yamaguchi, MD, PhD, Kazuhiro Asada, MD, PhD, Satoshi Tetsumoto, MD, PhD, Hiroshi Tanaka, MD, PhD, Satoshi Watanabe, MD, PhD, Yukihiro Umeda, MD, PhD, Kakuhiro Yamaguchi, MD, PhD, Shoichi Kuyama, MD, PhD, Kosuke Tsuruno, MD, PhD, Yuki Misumi, MD, PhD, Hiroshi Kuraishi, MD, PhD, Ken Yoshihara, MD, PhD, Akira Nakao, MD, PhD, Akihito Kubo, MD, PhD, Toshihiko Yokoyama, MD, PhD, Kana Watanabe, MD, PhD, Nobuhiko Seki, MD, PhD
المصدر: JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100593- (2023)
مصطلحات موضوعية: Necitumumab, Immune checkpoint inhibitor, Platinum rechallenge, Skin disorder, Lung squamous cell carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Motoko Tachihara, MD, PhD, Akito Hata, MD, Takaaki Tokito, MD, PhD, Satoshi Hara, MD, PhD, Hideaki Okada, MD, Satoru Miura, MD, PhD, Yuki Sato, MD, Eriko Tabata, MD, PhD, Hiroshi Watanabe, MD, PhD, Yusuke Takayama, MD, PhD, Ryo Toyozawa, MD, PhD, Keiichi Ota, MD, PhD, Kazushige Wakuda, MD, PhD, Atsushi Nakamura, MD, PhD, Mototsugu Shimokawa, PhD, Nobuyuki Yamamoto, MD, PhD, Kazuhiko Nakagawa, MD, PhD
المصدر: JTO Clinical and Research Reports, Vol 4, Iss 10, Pp 100569- (2023)
مصطلحات موضوعية: Docetaxel, Ramucirumab, Febrile neutropenia, pegylated-granulocyte-colony stimulating factor, elderly, Non–small cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
6دورية أكاديمية
المؤلفون: Hideki Terai, MD, Kenzo Soejima, MD, Asanao Shimokawa, PhD, Hidehito Horinouchi, MD, Junichi Shimizu, MD, Tetsunari Hase, MD, Ryota Kanemaru, MD, Kana Watanabe, MD, Kiichiro Ninomiya, MD, Naoko Aragane, MD, Noriko Yanagitani, MD, Yoshihiko Sakata, MD, Masahiro Seike, MD, Daichi Fujimoto, MD, Masashi Kasajima, MD, Akihito Kubo, MD, Sojiro Kusumoto, MD, Yoshitaka Oyamada, MD, Keiichi Fujiwara, MD, Masahide Mori, MD, Midori Hashimoto, MD, Masato Shingyoji, MD, Masahiro Kodani, MD, Jin Sakamoto, MD, Toshihiko Agatsuma, MD, Kosuke Kashiwabara, MD, Minehiko Inomata, MD, Motoko Tachihara, MD, Kazuhisa Tanaka, MD, Kenji Hayashihara, MD, Nobuyuki Koyama, MD, Kaoru Matsui, MD, Koichi Minato, MD, Daisuke Jingu, MD, Hiroyuki Sakashita, MD, Satoshi Hara, MD, Tomoyuki Naito, MD, Asuka Okada, MD, Masayuki Tanahashi, MD, Yuki Sato, MD, Koichiro Asano, MD, Takayuki Takeda, MD, Kensuke Nakazawa, MD, Toshiyuki Harada, MD, Kazuhiko Shibata, MD, Tatsuo Kato, MD, Etsuo Miyaoka, PhD, Ichiro Yoshino, MD, Akihiko Gemma, MD, Tetsuya Mitsudomi, MD
المصدر: JTO Clinical and Research Reports, Vol 3, Iss 11, Pp 100404- (2022)
مصطلحات موضوعية: Real-world data, Pembrolizumab, Immune checkpoint inhibitor, Immune-related adverse events, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource